S&P 500   3,169.26 (+1.31%)
DOW   27,437.34 (+1.31%)
QQQ   219.23 (+1.79%)
AAPL   293.29 (+1.81%)
FB   200.15 (+1.72%)
MSFT   171.98 (+2.33%)
GOOGL   1,402.89 (+1.20%)
AMZN   2,000.15 (+1.39%)
CGC   20.19 (+2.91%)
NVDA   271.02 (+3.42%)
BABA   211.12 (+2.68%)
MU   53.93 (+3.49%)
TSLA   791.11 (-1.10%)
AMD   48.80 (+2.59%)
T   37.29 (-0.16%)
ACB   1.53 (+1.33%)
F   7.45 (+2.90%)
NFLX   376.72 (+4.62%)
PRI   123.52 (+1.73%)
BAC   31.48 (+1.29%)
GILD   71.37 (+1.81%)
S&P 500   3,169.26 (+1.31%)
DOW   27,437.34 (+1.31%)
QQQ   219.23 (+1.79%)
AAPL   293.29 (+1.81%)
FB   200.15 (+1.72%)
MSFT   171.98 (+2.33%)
GOOGL   1,402.89 (+1.20%)
AMZN   2,000.15 (+1.39%)
CGC   20.19 (+2.91%)
NVDA   271.02 (+3.42%)
BABA   211.12 (+2.68%)
MU   53.93 (+3.49%)
TSLA   791.11 (-1.10%)
AMD   48.80 (+2.59%)
T   37.29 (-0.16%)
ACB   1.53 (+1.33%)
F   7.45 (+2.90%)
NFLX   376.72 (+4.62%)
PRI   123.52 (+1.73%)
BAC   31.48 (+1.29%)
GILD   71.37 (+1.81%)
S&P 500   3,169.26 (+1.31%)
DOW   27,437.34 (+1.31%)
QQQ   219.23 (+1.79%)
AAPL   293.29 (+1.81%)
FB   200.15 (+1.72%)
MSFT   171.98 (+2.33%)
GOOGL   1,402.89 (+1.20%)
AMZN   2,000.15 (+1.39%)
CGC   20.19 (+2.91%)
NVDA   271.02 (+3.42%)
BABA   211.12 (+2.68%)
MU   53.93 (+3.49%)
TSLA   791.11 (-1.10%)
AMD   48.80 (+2.59%)
T   37.29 (-0.16%)
ACB   1.53 (+1.33%)
F   7.45 (+2.90%)
NFLX   376.72 (+4.62%)
PRI   123.52 (+1.73%)
BAC   31.48 (+1.29%)
GILD   71.37 (+1.81%)
S&P 500   3,169.26 (+1.31%)
DOW   27,437.34 (+1.31%)
QQQ   219.23 (+1.79%)
AAPL   293.29 (+1.81%)
FB   200.15 (+1.72%)
MSFT   171.98 (+2.33%)
GOOGL   1,402.89 (+1.20%)
AMZN   2,000.15 (+1.39%)
CGC   20.19 (+2.91%)
NVDA   271.02 (+3.42%)
BABA   211.12 (+2.68%)
MU   53.93 (+3.49%)
TSLA   791.11 (-1.10%)
AMD   48.80 (+2.59%)
T   37.29 (-0.16%)
ACB   1.53 (+1.33%)
F   7.45 (+2.90%)
NFLX   376.72 (+4.62%)
PRI   123.52 (+1.73%)
BAC   31.48 (+1.29%)
GILD   71.37 (+1.81%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ESSA PharmaAduro BioTechTrillium TherapeuticsParatek PharmaceuticalsMarinus Pharmaceuticals
SymbolNASDAQ:EPIXNASDAQ:ADRONASDAQ:TRILNASDAQ:PRTKNASDAQ:MRNS
Price Information
Current Price$5.25$3.43$3.75$3.79$2.85
52 Week RangeBuyHoldBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$8.00$5.50$4.00$17.33$5.95
% Upside from Price Target52.38% upside60.35% upside6.67% upside357.34% upside108.77% upside
Trade Information
Market Cap$106.09 million$299.51 million$109.91 million$117.17 million$154.07 million
Beta2.011.412.841.843.22
Average Volume39,9461,963,5631,635,355470,5911,022,895
Sales & Book Value
Annual RevenueN/A$15.09 millionN/A$17.12 millionN/A
Price / SalesN/A18.30N/A7.37N/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$2.22 per share$1.70 per share($0.32) per share$1.48 per share$1.30 per share
Price / BookN/A2.02N/A2.56N/A
Profitability
Net Income$-10,440,000.00$-95,360,000.00$-25,290,000.00$-112,360,000.00$-36,730,000.00
EPS($1.46)($1.16)($2.36)($3.57)($0.90)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-544.94%N/A-505.07%N/A
Return on Equity (ROE)-49.03%-78.64%-5,566.05%-5,327.73%-94.47%
Return on Assets (ROA)-41.06%-25.00%-66.75%-45.09%-78.87%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.39%N/AN/AN/A
Current Ratio38.04%7.26%2.66%9.80%4.80%
Quick Ratio38.04%7.26%2.66%9.45%4.80%
Ownership Information
Institutional Ownership Percentage67.10%39.50%30.45%68.35%N/A
Insider Ownership PercentageN/A5.20%N/A7.70%5.10%
Miscellaneous
Employees15152N/A10128
Shares Outstanding20.76 million80.51 million28.04 million33.29 million53.87 million
Next Earnings Date5/8/2020 (Estimated)2/26/2020 (Estimated)3/9/2020 (Estimated)N/A3/9/2020 (Estimated)
OptionableNot OptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel